Biotechno¬logies Using Baeyer-Villiger Oxidations

Page: 750

A. Schenkmayerová, M. Bučko, and P. Gemeiner

Department of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Bratislava

 

Baeyer-Villiger (B-V) biooxidations catalyzed by B-V monooxygenases have been studied because their products are precursors of important pharmaceuticals including antiviral, antifungal, antileukemic or anticancer drugs. Some improvement of biotransformation yields at lowest costs are investigated including immobilized B-V bio¬catalysts. This review contains the relevant information.

 

Full text (PDF)